Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6181 6182 6183 6184 6185 6186 6187 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
#
NCTID/Status
Study
Last Changed
310001
NCT00136838
Completed
Completed
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
Conditions: Tobacco Use Disorder
Intervention: Neutral Or Active Cigarette Cues
Conditions: Tobacco Use Disorder
Intervention: Neutral Or Active Cigarette Cues
May 17, 2018
310002
NCT00136825
Completed
Completed
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
Conditions: Cocaine-Related Disorders
Intervention: N-Acetylcysteine, Placebo
Conditions: Cocaine-Related Disorders
Intervention: N-Acetylcysteine, Placebo
January 11, 2017
310003
NCT00136812
Completed
Completed
Treating Tobacco Dependence in Inpatient Psychiatry - 1
Conditions: Tobacco Use Cessation; Tobacco Use Disorder
Intervention: Stage-tailored Intervention
Conditions: Tobacco Use Cessation; Tobacco Use Disorder
Intervention: Stage-tailored Intervention
April 23, 2016
310004
NCT00136799
Completed
Completed
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
Conditions: Mixed Dyslipidemia; Hypercholesterolemia
Conditions: Mixed Dyslipidemia; Hypercholesterolemia
February 20, 2017
310005
NCT00136786
Completed
Completed
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3
Conditions: Tobacco Use Disorder
Intervention: Memantine
Conditions: Tobacco Use Disorder
Intervention: Memantine
May 17, 2018
310006
NCT00136773
Completed
Completed
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Conditions: Albuminuria
Intervention: Amlodipine/benazepril
Conditions: Albuminuria
Intervention: Amlodipine/benazepril
March 8, 2011
310007
NCT00136760
Completed
Completed
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Conditions: Schizophrenia and Disorders With Psychotic Features; Tobacco Use Disorder
Intervention: Bupropion, Contingent Reinforcement Plus Placebo, Non-contingent Reinforcement Plus Bupropion, Non-contingent Reinforcement Plus Placebo
Conditions: Schizophrenia and Disorders With Psychotic Features; Tobacco Use Disorder
Intervention: Bupropion, Contingent Reinforcement Plus Placebo, Non-contingent Reinforcement Plus Bupropion, Non-contingent Reinforcement Plus Placebo
October 5, 2015
310008
NCT00136747
Completed
Completed
The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1
Conditions: Tobacco Use Disorder
Intervention: Memantine, Bupropion, Placebo
Conditions: Tobacco Use Disorder
Intervention: Memantine, Bupropion, Placebo
May 17, 2018
310009
NCT00136734
Completed
Completed
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
Conditions: Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders
Intervention: Methylphenidate, Placebo
Conditions: Attention Deficit Disorder With Hyperactivity; Cocaine-Related Disorders
Intervention: Methylphenidate, Placebo
April 22, 2019
310010
NCT00136721
Unknown status
Unknown status
Parkin Mutations and Their Functional Consequences
Conditions: Parkinson's Disease
Conditions: Parkinson's Disease
December 3, 2007
310011
NCT00136708
Completed
Completed
First Breath: Neonatal Resuscitation in Developing Countries
Conditions: Asphyxia Neonatorum
Intervention: Neonatal Resuscitation
Conditions: Asphyxia Neonatorum
Intervention: Neonatal Resuscitation
July 29, 2014
310012
NCT00136695
Completed
Completed
Anastrozole Administration in Elderly Hypogonadal Men
Conditions: Hypogonadism
Intervention: Anastrozole
Conditions: Hypogonadism
Intervention: Anastrozole
November 30, 2016
310013
NCT00136682
Completed
Completed
Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery
Conditions: Postoperative Pain
Intervention: Patient-controlled Epidural Analgesia (PCEA), Patient-controlled Intravenous Analgesia (PCA)
Conditions: Postoperative Pain
Intervention: Patient-controlled Epidural Analgesia (PCEA), Patient-controlled Intravenous Analgesia (PCA)
November 6, 2008
310014
NCT00136669
Completed
Completed
Acupuncture For Pancreatic Cancer Pain
Conditions: Pancreatic Neoplasms; Pain
Intervention: Acupuncture
Conditions: Pancreatic Neoplasms; Pain
Intervention: Acupuncture
September 7, 2006
310015
NCT00136656
Completed
Completed
Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old
Conditions: Pyelonephritis
Intervention: Antibiotic, Antibiotics
Conditions: Pyelonephritis
Intervention: Antibiotic, Antibiotics
February 11, 2009
310016
NCT00136643
Completed
Completed
Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women
Conditions: HIV Infections; Sexually Transmitted Diseases
Intervention: Invisible Condom®
Conditions: HIV Infections; Sexually Transmitted Diseases
Intervention: Invisible Condom®
October 9, 2007
310017
NCT00136630
Unknown status
Unknown status
Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Conditions: Spinocerebellar Ataxias; Spastic Paraplegias
Conditions: Spinocerebellar Ataxias; Spastic Paraplegias
January 27, 2012
310018
NCT00136617
Completed
Completed
Outpatient Treatment of Alcohol Withdrawal Syndrome
Conditions: Alcoholism; Alcohol Withdrawal
Intervention: Chlordiazepoxide
Conditions: Alcoholism; Alcohol Withdrawal
Intervention: Chlordiazepoxide
February 27, 2009
310019
NCT00136604
Completed
Completed
Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
Conditions: Whole Cell Pertussis; Haemophilus Influenzae Type b; Hepatitis B; Diphtheria; Tetanus
Intervention: Tritanrix-HepB, Mencevax™ ACWY, Hiberix™, Meningitec™, Hib-MenAC-TT
Conditions: Whole Cell Pertussis; Haemophilus Influenzae Type b; Hepatitis B; Diphtheria; Tetanus
Intervention: Tritanrix-HepB, Mencevax™ ACWY, Hiberix™, Meningitec™, Hib-MenAC-TT
February 5, 2018
310020
NCT00136591
Terminated
Terminated
A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
Conditions: Follicular Lymphoma
Intervention: Bortezomib, Bortezomib
Conditions: Follicular Lymphoma
Intervention: Bortezomib, Bortezomib
October 22, 2010
310021
NCT00136578
Completed
Completed
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors
Conditions: Solid Tumours
Intervention: SB-715992, Carboplatin
Conditions: Solid Tumours
Intervention: SB-715992, Carboplatin
September 22, 2017
310022
NCT00136565
Completed
Completed
Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma
Conditions: Peripheral T-cell Lymphoma
Intervention: Velcade, Doxorubicin, Prednisone, Cyclophosphamide, Vindesine, Bleomycin
Conditions: Peripheral T-cell Lymphoma
Intervention: Velcade, Doxorubicin, Prednisone, Cyclophosphamide, Vindesine, Bleomycin
August 21, 2018
310023
NCT00136552
Completed
Completed
Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden
Conditions: Lymphoma
Intervention: Rituximab
Conditions: Lymphoma
Intervention: Rituximab
July 2, 2007
310024
NCT00136539
Completed
Completed
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer
Conditions: Breast Cancer
Intervention: Herceptin, Taxol, Adriamycin, Cytoxan
Conditions: Breast Cancer
Intervention: Herceptin, Taxol, Adriamycin, Cytoxan
February 15, 2013
310025
NCT00136526
Completed
Completed
Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
Conditions: Prostate Cancer
Intervention: Docetaxel And Diethylstilbestrol (DES)
Conditions: Prostate Cancer
Intervention: Docetaxel And Diethylstilbestrol (DES)
May 7, 2013
310026
NCT00136513
Completed
Completed
October 15, 2008
310027
NCT00136500
Recruiting
Recruiting
Clinical Research in ALS Study
Conditions: Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis
July 31, 2019
310028
NCT00136487
Completed
Completed
Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
Conditions: Prostate Cancer
Intervention: Celecoxib
Conditions: Prostate Cancer
Intervention: Celecoxib
December 7, 2009
310029
NCT00136474
Completed
Completed
Amifostine for Head and Neck Irradiation in Lymphoma
Conditions: Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
Intervention: Amifostine, Radiation Therapy
Conditions: Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
Intervention: Amifostine, Radiation Therapy
October 30, 2009
310030
NCT00136461
Completed
Completed
A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome
Intervention: All-trans Retinoic Acid, Bryostatin 1
Conditions: Acute Myelogenous Leukemia; Myelodysplastic Syndrome
Intervention: All-trans Retinoic Acid, Bryostatin 1
March 9, 2011
310031
NCT00136448
Completed
Completed
High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML)
Conditions: Acute Myelogenous Leukemia
Intervention: Cytosine Arabinoside (ara-C), Daunomycin, Interleukin-2
Conditions: Acute Myelogenous Leukemia
Intervention: Cytosine Arabinoside (ara-C), Daunomycin, Interleukin-2
March 9, 2011
310032
NCT00136435
Active, not recruiting
Active, not recruiting
A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia
Intervention: Prednisone, Doxorubicin, Vincristine, Methotrexate, Asparaginase, Dexamethasone, Cranial Radiation, Leucovorin, Cytarabine, Hydrocortisone, 6-mercaptopurine (6-MP), E. Coli L-asparaginase
Conditions: Acute Lymphoblastic Leukemia
Intervention: Prednisone, Doxorubicin, Vincristine, Methotrexate, Asparaginase, Dexamethasone, Cranial Radiation, Leucovorin, Cytarabine, Hydrocortisone, 6-mercaptopurine (6-MP), E. Coli L-asparaginase
June 18, 2019
310033
NCT00136422
Completed
Completed
Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia; Myelodysplasia
Intervention: Autologous Tumor Cells
Conditions: Acute Myelogenous Leukemia; Myelodysplasia
Intervention: Autologous Tumor Cells
March 9, 2011
310034
NCT00136409
Completed
Completed
A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML)
Conditions: Myelofibrosis; Myeloid Metaplasia; Agnogenic Myeloid Metaplasia; Chronic Myelomonocytic Leukemia
Intervention: Imatinib Mesylate
Conditions: Myelofibrosis; Myeloid Metaplasia; Agnogenic Myeloid Metaplasia; Chronic Myelomonocytic Leukemia
Intervention: Imatinib Mesylate
December 22, 2016
310035
NCT00136396
Completed
Completed
Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease
Conditions: Graft vs Host Disease
Intervention: Rituximab
Conditions: Graft vs Host Disease
Intervention: Rituximab
June 10, 2013
310036
NCT00136383
Completed
Completed
Comparing Paroxetine and Duloxetine on Cardiovascular Measures
Conditions: Depressive Symptoms
Intervention: Paroxetine Versus Duloxetine
Conditions: Depressive Symptoms
Intervention: Paroxetine Versus Duloxetine
July 18, 2014
310037
NCT00136370
Unknown status
Unknown status
Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and Newborn
Conditions: Infant, Newborn, Diseases; Sepsis; Puerperal Infection
Intervention: Chlorhexidine, Birth Canal Wipe, Sterile Water External Genital Wipe
Conditions: Infant, Newborn, Diseases; Sepsis; Puerperal Infection
Intervention: Chlorhexidine, Birth Canal Wipe, Sterile Water External Genital Wipe
September 21, 2007
310038
NCT00136357
Completed
Completed
Treatment of Posttraumatic Stress Disorder in Kosovar High School Students Using Mind-Body Skills Groups
Conditions: Stress Disorders, Post-traumatic
Intervention: Mind-Body Skills Groups
Conditions: Stress Disorders, Post-traumatic
Intervention: Mind-Body Skills Groups
February 2, 2015
310039
NCT00136344
Completed
Completed
Study of Antibiotic Prophylaxis for Endophthalmitis Following Cataract Surgery
Conditions: Endophthalmitis
Intervention: Cefuroxime, Levofloxacin
Conditions: Endophthalmitis
Intervention: Cefuroxime, Levofloxacin
February 11, 2016
310040
NCT00136331
Completed
Completed
Study of a Pandemic Influenza Vaccine
Conditions: Influenza
Intervention: Pandemic Influenza Vaccine
Conditions: Influenza
Intervention: Pandemic Influenza Vaccine
July 17, 2016
310041
NCT00136318
Completed
Completed
Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
Conditions: Depression
Intervention: Escitalopram, Placebo, Peginterferon Alfa-2a, Ribavirin
Conditions: Depression
Intervention: Escitalopram, Placebo, Peginterferon Alfa-2a, Ribavirin
March 20, 2013
310042
NCT00136305
Terminated
Terminated
Comparing Asthma Action Plans for Pediatric Asthma
Conditions: Asthma
Conditions: Asthma
February 3, 2015
310043
NCT00136292
Completed
Completed
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
Conditions: Gram-positive Bacterial Infections
Intervention: Daptomycin
Conditions: Gram-positive Bacterial Infections
Intervention: Daptomycin
December 19, 2017
310044
NCT00136279
Completed
Completed
Linking Lives: Building Quality Parent Components for School-Based Health Programs in Middle Schools
Conditions: Smoking; Sexual Behavior
Intervention: Linking Lives Parent-based Intervention
Conditions: Smoking; Sexual Behavior
Intervention: Linking Lives Parent-based Intervention
January 30, 2009
310045
NCT00136266
Completed
Completed
Adherence With Iron Sprinkles Among High-Risk Infants
Conditions: Anemia; Iron Deficiency
Intervention: Ferrous Sulphate Drops With Vitamins A, D, And C, Ferrous Fumarate Sprinkles With Vitamins And Minerals
Conditions: Anemia; Iron Deficiency
Intervention: Ferrous Sulphate Drops With Vitamins A, D, And C, Ferrous Fumarate Sprinkles With Vitamins And Minerals
February 2, 2016
310046
NCT00136253
Completed
Completed
Overcoming Nutritional Barriers in Hemodialysis Patients
Conditions: End Stage Renal Disease
Intervention: Help Dietitians And Patients Address Specific Nutritional Barriers
Conditions: End Stage Renal Disease
Intervention: Help Dietitians And Patients Address Specific Nutritional Barriers
December 12, 2005
310047
NCT00136240
Completed
Completed
Automated Telephone System to Improve Treatment Adherence in People With Depression
Conditions: Depression
Intervention: Computer Assisted Education For Behavior Change
Conditions: Depression
Intervention: Computer Assisted Education For Behavior Change
July 24, 2013
310048
NCT00136227
Completed
Completed
Use and Decision-making About Colorectal Cancer Screening Among Hispanic Men and Women
Conditions: Colorectal Cancer
Intervention: Small Media Intervention Using Video, Flip Chart, And Pamphlets And A Tailored Interactive Multimedia Intervention
Conditions: Colorectal Cancer
Intervention: Small Media Intervention Using Video, Flip Chart, And Pamphlets And A Tailored Interactive Multimedia Intervention
September 6, 2012
310049
NCT00136214
Completed
Completed
Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
Conditions: Hepatitis C
Intervention: MR Brain And Neuropsychiatric Tests
Conditions: Hepatitis C
Intervention: MR Brain And Neuropsychiatric Tests
June 20, 2018
310050
NCT00136201
Completed
Completed
Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
Conditions: Abdominal Abscess
Intervention: Tigecycline
Conditions: Abdominal Abscess
Intervention: Tigecycline
July 6, 2009
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6181 6182 6183 6184 6185 6186 6187 6188 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.